The effects of enhanced re d blood cell (RBC) aggregation on nitric oxide (NO) dependent vascular control mechanisms have been investigated in a rat exchange transfusion model. RBC aggregation for cells in native plasma was increased via a novel method using RBC covalently coated w ith a 13 kDa poloxamer copolymer (Pluronic F98); control experiments used RBC coated with a non-aggregating 8.4 kDa poloxamer (Pluronic F68). Rats exchange-transfused with aggregating RBC suspensions demonstrated significantly enhanced RBC aggregation throughout the five day follow-up period, with mean arterial blood pressure increasing gradually over this period. Arterial segments (≈ 300 µm diameter) were isolated from gracilis muscle on the fifth day and mounted between two glass micropipettes in a special chamber equipped with pressure servo control system. Dose dependent dilation by acetylcholine and flow-mediated dilation of arterial segments pressurized to 30 mmHg and pre-constricted to 45-55% of the original diameter by phenylephrine were significantly blunted in rats with enhanced RBC aggregation. Both responses were totally abolished by non-specific NOS inhibitor (L-NAME) treatment of arterial segments, indicating that the responses were NO-related. Additionally, expression of eNOS protein was found to be decreased in muscle samples obtained from rats exchanged with aggregating cell suspensions. These results imply that enhanced RBC aggregation results in suppressed expression of NO synthesizing mechanisms, thereby leading to altered vasomotor tonus: the mechanisms involved most likely relate to decreased wall shear stresses due to decreased blood flow and/or increased axial accumulation of RBC.
INTRODUCTION
Nitric oxide (NO) plays a key role in the control of circulatory function (21) , and the importance of NO in the regulation of vascular smooth muscle tone and the maintenance of vascular resistance has been well established (13, 38, 44) . In addition, several other physiological functions (e.g., apoptosis) have been attributed to this simple molecule (9, 25) . Endothelial cells are the source of NO that modulates vascular resistance: NO diffuses to the underlying vascular smooth muscle where it activates guanylate cyclase to increase cyclic GMP, thus resulting in smooth muscle relaxation (26) and decreased vascular resistance.
Endothelial NO is synthesized by the endothelial isoform of the NO synthase, termed eNOS, using L -arginine as substrate (31) . While eNOS is continuously expressed at a basal level in endothelial cells, its activation is dependent on calciumcalmodulin complex levels and thus NO generation by endothelial cells is dependent on intracellular calcium concentration (41) . It has been shown that this calciumdependent regulation of NO synthesis in the endothelial cells is closely related to the hemodynamic conditions to which they are exposed (39) : mechanical forces acting on endothelial cells trigger calcium entry and activate eNOS (54) . Mechanical forces acting on endothelial cells can also activate eNOS by phosphorylation through calcium-independent mechanisms (15, 29, 54) . Additionally, eNOS expression in endothelial cells can be modulated by the magnitude of the mechanical forces to which they are exposed (46, 53, 58) .
Mechanical forces acting on endothelial cells in vivo are due to blood flow over these cells (i.e., tangential forces) and can be quantitated as wall shear stress: the magnitude of the wall shear stress is determined by the product of the fluid velocity profile adjacent to the vessel wall (i.e., wall shear rate) and the apparent viscosity of the fluid in this marginal area (33, 42) . It has been demonstrated in a number of studies that alterations in hemodynamic conditions and wall shear stress may affect NO synthesizing mechanisms in the vascular endothelium. Cardiac failure induced by coronary artery ligation, and hence decreased blood flow rates, leads to significantly diminished eNOS expression in skeletal muscle sam ples (55) . This alteration can be reversed by regular exercise, indicating the importance of blood flow rate in maintaining physiological eNOS expression levels (55) . These observations are supported by studies demonstrating enhanced eNOS expression in various regions of the circulatory system by regular exercise (24, 28, 30) and by increased blood flow due to arteriovenous shunts (23, 39) .
The abovementioned definition of wall shear stress suggests a significant role for the physical (i.e., rheological) properties of the blood in close contact with the vessel wall (33, 42) . It is well known that the composition of blood across the diameter of a blood vessel is not uniform (20) . Rather, red blood cells (RBC) tend to migrate toward the axis, resulting in a plasma-rich, cell-poor marginal layer with relatively lower viscosity (16, 20) . The extent of RBC axial migration is strongly affected by their tendency for aggregation, such that an enhanced tendency for RBC aggregation promotes axial migration (16) and, under appropriate conditions, decreases flow resistance (6, 16, 47) . Soutani et al. clearly demonstrated the existence of this cell-poor layer and the influence of RBC aggregation on its thickness in an in vivo study using rabbit mesentery (50) . They suggest ed that the widening of cell-poor layer tends to reduce the flow resistance in the microvascular network (50) .
However, it should be noted that the effects of RBC aggregation on flow dynamics are highly complex, and are modulated by a number of factors such as the orientation of blood vessels versus gravity (20) and transit times (i.e., flow times) through a given vessel segment (11) .
The present study was designed to test the hypothesis that enhanced RBC aggregation would yield diminished eNOS expression as a result of decreased wall shear stress due to decreased blood flow rates and/or more effective RBC axial migration. In contrast with previous reports that employed the addition of high molecular weight water-soluble polymer solutions to circulating blood (e.g., 6, 11, 19, 35, 48) , enhanced RBC aggregation was achieved in this study by covalent attachment of a 13 kDa poloxamer (Pluronic F98) to the RBC surface (5). This technique allows controllable augmentation of RBC aggregation without diluting plasma proteins and does not involve chemical or viscosity changes of the plasma.
Attachment of a 8.4 kDa poloxamer (Pluronic F68) to the RBC does not alter aggregation for cells in plasma, thereby allowing control experiments that are closely matched to the group with enhanced aggregation.
MATERIALS AND METHOD S
Animals: Adults rats of either sex weighing 250-300 grams were used for this study, and were randomly assigned to each arm of the exchange transfusion protocol (see below) or to serve as blood donors. Blood from donor animals was obtained from their abdominal aorta under light ether anesthesia, anticoagulated with EDTA (1.5 mg/ml) and used for preparing polymer-coated RBC suspensions. The experimental protocol was approved by the Animal Care and Usage Committee of Akdeniz University and was in accordance with the Declaration of Helsinki and IASP guidelines.
Modification of the RBC aggregation:
Enhanced RBC aggregation was achieved by employing a novel technique whereby copolymers that possess the ability to selfassociate above a specific temperature have been covalently attached to the RBC surface. These copolymers, known as poloxamers, are triblock macromolecules comprised of a central hydrophobic block of poly(propylene glycol) (PPG) flanked by two identical hydrophilic poly(ethylene glycol) (PEG) chains (49) . Poloxamers exhibit a critical micellization temperature (CMT) at which a phase transition occurs from predominantly single, fully hydrated copolymer chains to micelle-like structures characterized by association of the hydrophobic PPG blocks (2, 3, 8) . The CMT decreases with increasing mass of the PPG block, and by proper selection of the poloxamer (8), RBC aggregation can be controllably and predictably enhanced or inhibited following covalent attachment to the RBC surface (5) . That is, at temperatures above the CMT, poloxamers attached to the RBC surface micellize with poloxamers on adjacent RBC thereby enhancing RBC aggregation -the strength of the association being dependent on the poloxamer type, concentration and temperature (5) . Conversely, below the CMT, poloxamers attached to the RBC surface inhibit RBC aggregation due to polymer-polymer repulsion.
Derivatization of poloxamers:
Pluronic copolymers were a gift from BASF Performance Chemicals, Parsippany, NJ. These poloxamers contained 80% poly(ethylene glycol) by mass and had the following designations and molecular weights: Pluronic F68, 8.4 kDa; Pluronic F98, 13.0 kDa. To facilitate covalent attachment of the poloxamers to the RBC surface a reactive derivative of the copolymers was first prepared. This was achieved by converting the terminal hydroxyl groups of the copolymer chain to succinimidyl carbonate (SC) groups using a modification of the method described by Miron and Wilchek (36) . In brief, 1 mmol of poloxamer was dissolved in 100 ml of dioxane (warmed slightly to aid dissolution) and then cooled to room temperature; the clear solution was stirred using a magnetic stirrer and purged with nitrogen. A three-fold molar excess (6 mmol) of N,N'-disuccinimidyl carbonate was then slurried in 10 ml of dry acetone and added to the solution. Six mmol of 4-(dimethylamino)pyridine was dissolved in 20 ml of dry acetone, added slowly to the reaction mixture, and the reaction allowed to proceed for 24 h at room temperature under nitrogen. The reaction mixture was filtered to remove any solid precipitate, and the filtrate poured slowly under high shear into 300 ml of diethyl ether to precipitate the derivatized poloxamer and remove the 4-(dimethylamino)pyridine. The precipitate was filtered and washed with 200 ml of diethyl ether, resuspended in 200 ml of isopropanol, filtered and washed with 100 ml of isopropanol to remove any unreacted N,N'-disuccinimidyl carbonate. The precipitate was then resuspended in 200 ml cyclolhexane, filtered and washed with 100 ml cyclohexane. Finally, the poloxamer succinimidyl carbonate derivatives (Pluronic F68-SC and Pluronic F98-SC) were dried under a stream of dry nitrogen for 12 h.
RBC coating:
In order to achieve an even coating of poloxamer, and to avoid the formation of cross -linked aggregates of coated RBC, all poloxamer-coating procedures were performed at 4 °C (i.e., below the poloxamer critical micellization temperature). Blood was centrifuged at 1400 x g for six minutes and the plasma was separated and saved. RBC were washed three times with isotonic phosphate buffered saline (PBS, pH 7.4), re-suspended in 30 mM triethanolamine buffer (290 mOsm/kg, pH 8.60) at a hematocrit of ~0.1 L/L, a nd the suspension cooled to 4 °C.
Immediately prior to use, the reactive poloxamer to be used for coating RBC (either Pluronic F68-SC or Pluronic F98-SC) was dissolved in a 4 °C hypotonic phosphate buffer (50mM NaH2PO4, 60mM NaCl; pH 5) at a concentration of 10 mg/mL. The Blood pressure following the exchange transfusion was measured daily over a four-day follow-up period using a tail-cuff method (BP HR200 Module plus MP100 system, Biopac S ystems Inc., Goleta, CA). Additionally, blood samples were obtained from tail tips of the rats every day during this period and used for microscopic examinations. Wet mount preparations of dilute RBC suspensions were examined and photographed using bright field light microscopy. These photographs were used to assess RBC aggregation via the Microscopic Aggregation Indexes (MAI) technique (45) . In the MAI method, the total number of RBC in a field is divided by the number of RBC units (i.e., sum of the number of individual RBC and aggregates) in the same field; the MAI has a value of unity in the absence of aggregation and increases with enhanced RBC aggregation (45) .
In a separate series of experiments, 2 mg of reactive Pluronic F68 or F98 in 0.1 mL isotonic saline was infused into the tail vein of rats (n=4 for each poloxamer)
daily over a four-day period. Arterial blood pressure and RBC aggregation were monitored during this period using the methods described above to test the effect of free polymers o n these parameters. These experiments were repeated using inactivated polymers (i.e., polymers incubated overnight at pH=8 at room temperature) for daily injections.
In vitro vascular studies: On the fourth day after the exchange transfusion, rats were anesthetized by urethane (1 g/kg, 20% in isotonic saline).The gracilis muscle from the left leg of the animal was excised, transferred to a dissecting dish containing oxygenated Kreb's solution, and an arterial segment of ~300 µm diameter was isolated from the muscle under a dissection microscope. PVDF membranes were also used for determining glyceraldehyde-3 -phosphatedehydro-genase (GAPDH) expression, as the loading standard, as described above using GAPDH primer antibody (ab8245, Abcam Ltd., Cambridge, UK). The intensities of the bands were quantified by densitometric analysis using a gel scanner (Cobrascan CX 312 T; Radiographic Digital Imaging, Inc., Torrance, CA, USA), with the results expressed as the ratio of densities of eNOS specific bands to GAPDH bands.
Statistics:
The results obtained from F68 and F98 groups were compared by "Student's t test", where appropriate. Multiple comparisons were done by "One-way ANOVA" followed by "Newman-Keuls Post Test" or "Two-way ANOVA followed by Blood pressure: Mean arterial pressure values measured using a tail cuff method are presented in Figure 3 , where it can be seen that there was no alteration in arterial pressure in the F68 group during the days following the exchange transfusions.
RESULTS

RBC aggregation:
Conversely, in the group that received exchange transfusions with F98-coated RBC suspensions there was a gradual increase in mean arterial pressure. Significantly higher values were recorded in this group on and after the second day following exchange transfusions: mean arterial pressure was significantly higher than both the baseline values (i.e., the values before the exchange transfusion) and those for the value for acetylcholine was found to be 2.07x10 -7 M in F68 group, while in F98 group the EC50 value was approximately 17 times higher (3.48x10 -6 M).
Flow-mediated dilation:
Responses of pressurized and pre-constricted arterial segments to alterations in fluid flow rate through the segments are presented in Figure 6 . Flow-mediated dilation at flow rates of 8 and 17 µL/min were significantly greater in the F68 group compared to the F98 group. Flow -mediated dilation reached its maximum at 17 µL/min in the F68 group, while in the F98 group the maximum response to flow was observed at 26 µL/min ( Figure 5 ). The flow rate-dilation curve in the F68 group was similar to that obtained using arterial segments isolated from normal, non-operated rats (data not shown). Prior L -NAME incubation of the arterial segments for 30 minutes abolished the flow mediated dilation responses in both groups.
eNOS expression: Western blotting results revealed that eNOS expression was markedly reduced in the F98 group four days after the exchange transfusion ( Figure   6 ): the ratio of eNOS band density to GAPDH band density was 3.2 times higher in the F68 group compared to the F98 group. There was no significant difference between the values of the F68 group and non-operated control animals that did not receive exchange transfusions.
DISCUSSION
Using a rat exchange transfusion protocol involving RBC coated with a proaggregating poloxamer (i.e., Pluronic F98), the results of the current study demonstrate that: 1) increased RBC aggregation leads to a gradual increment of arterial blood pressure; 2) the increment of blood pressure is accompanied by impaired NO-mediated vasodilatory responses together with a diminished expression of eNOS in vessels of skeletal muscle. Control experiments using RBC coated with a non-aggregating poloxamer (i.e., Pluronic F68) indicated no changes of arterial blood pressure or eNOS expression. The relationship between NO synthesis and blood pressure is well known: interventions to suppress NO synthesis by endothelial cells have been used as hypertension models (12, 58) , and increased arterial pressure is known to alter NO -related vascular control mechanisms (40) . The relationship between RBC aggregation and arterial blood pressure is also well known, at least from clinical observations (1, 32) . It is thus suggested that the present study provides some insight to these complex relationships that are based on different types of observations.
Arterial blood pressure is directly proportional to the product of cardiac output and peripheral vascular resistance, with peripheral vascular resistance determined by vascular geometry, primarily blood vessel diameter, and the rheological properties of blood (14) . RBC aggregation is one of the main determinants of blood's rheological behavior, with increased aggregation resulting in elevated blood viscosity at low to medium rates of shear (7). Thus, based upon in vitro viscometric data, enhanced RBC aggregation would increase blood viscosity and flow resistance in large blood vessels. RBC aggregates should be dispersed (i.e., disaggregated) as they approach the microcirculation, where the size of blood vessels approaches that of individual RBC; the energy cost of such disaggregation would increase if the aggregation tendency of RBC is enhanced (56) . Therefore, increased hemodynamic resistance might be expected to be coincident with the step-wise increase of RBC aggregation resulting from the exchange transfusion with F98-coated RBC:
enhanced RBC aggregation would thus be the direct cause of the observed increase of arterial blood pressure (Figure 3 ). Given such a mechanism, arterial blood pressure should have reached a maximum immediately after the rapid increase of RBC aggregation and then gradually returned toward control as RBC aggregation tended to decrease (Figure 2 ). However, our experimental data do not support this prediction: mean arterial blood pressure rose gradually over the four-day follow up period while RBC aggregation decreased about 30% (Figures 2 and 3) .
The lack of a close temporal linkage between increases of RBC aggregation and arterial blood pressure suggests the need to consider other mechanisms. For example, it could be suggested that the gradual increase of arterial blood pressure might be independent of RBC aggregation and rather related to delayed release of poloxamer from the RBC surface. If true, then infused poloxamer should be expected to have an effect on arterial blood pressure. However, a separate series of studies in rats indicated that daily injections of reactive Pluronic F68 or F98 over a four-day period did not lead to an increase of arterial blood pressure although strong RBC aggregation was observed in peripheral blood samples during the first 4 hours following infusions. This short-term increase in RBC aggregation can be explained by covalent attachment of poloxamers to plasma proteins and crosslinking of plasma proteins by the reactive poloxamer (both Pluronic F68 and F98), thereby inducing strong aggregation by markedly increasing the effective macromolecular size of plasma proteins. Note, however, that these short-term increases of aggregation had no meaningful effects on arterial pressure. Further, in the event that the poloxamers did detach from the RBC surface in vivo, these "free" copolymers would be inactive and would not covalently attach to plasma proteins. Inactivated poloxamers were shown to be ineffective on both RBC aggregation and arterial blood pressure. These observations thus exclude the possibility of an effect of poloxamers (Pluronic F68 and F98) on blood pressure that is independent of long-term enhancement of RBC aggregation.
Although the in vitro viscometric data suggest increased vascular resistance to blood flow due to increased RBC aggregation, the effects of RBC aggregation on blood flow in vivo are controversial. Dispersion of strongly aggregated RBC at the microvascular level requires additional energy, yet widening of the cell-poor marginal layer near the vessel wall due to aggregation tends to decrease in vivo flow resistance (52) . Therefore, the net effect of increased RBC aggregation at a given time point would reflect the interplay between these two opposite influences.
Furthermore, it is now well established that the flow conditions in the vascular system Enhanced RBC aggregation would als o tend to promote axial accumulation of RBC in blood vessels, resulting in a less-viscous, plasma-rich region near vessel walls (16) .
Diminished wall shear stress resulting from this non-uniform radial composition of blood should be expected to influence the NO-related mechanisms in blood vessels (16, 20, 33) . Note that these two suggestions (i.e., decreased blood flow, less-viscous region near vessel walls) are not mutually exclusive and most likely are synergistic in decreasing mechanical forces acting on endothelial cells (10, 11, 59 ).
Regardless of the specific mechanism(s) responsible for reduced fluid forces at vessel walls, such reductions should result in shifted vasomotor balance and increased peripheral resistance due to diminished NO generation by endothelial cells.
Altered wall shear stress may affect NO synthesis by the constitutive NOS existing in endothelial cells, and the molecular mechanisms of eNOS activation by mechanical shear stress acting on endothelial cells have been the subject of several studies (15, 29, 52) . It has also been demonstrated that wall shear stress modulates the expression of eNOS protein (17, 18, 53) . However, the time scales for these two effects of shear stress differ. That is, while the modulation of existing eNOS activity follows rapidly after hemodynamic alterations, alteration of eNOS protein expression is known to occur over a longer span of time (23, 46) . For example, while NO -related mechanisms in skeletal muscle are known to play a significant role in vascular adjustments during exercise (27, 34) , regular physical exercise requires several weeks to induce increments in eNOS expression (24, 28, 30) . It thus seems likely that the gradual increase of arterial blood pressure seen in the present study (Figure 3) reflects the gradual down-regulation of eNOS protein expression due to decreased shear forces on endothelial cells. This suggestion is supported by the suppressed NO-mediated dilation (both acetylcholine and flow induced) responses (Figures 4 and   5 ) and the markedly decreased eNOS expression in skeletal muscle samples on the day when arterial pressure was significantly higher than the control group ( Figure 6 ).
It should be noted that vascular endothelium might not be the only source of eNOS in the muscle tissue samples used herein for Western blotting analysis. It has been demonstrated that eNOS is expressed by rat skeletal muscle cells and is most probably localized to mitochondria (51) . Although the level of eNOS expression in skeletal muscle cells was reported to be low (51), the relative contribution of eNOS from endothelial cells to the total eNOS determined in this study is somewhat uncertain. Unfortunately, it was technically impossible to isolate enough resistance blood vessel tissue from ra t skeletal muscles and total total muscle tissue samples were employed. However, it seems highly unlikely that the skeletal muscle cell eNOS expression would be modified by the altered hemodynamic conditions: the existing literature clearly indicates a va scular origin for altered eNOS expression due to altered hemodynamics (30, 37, 55) . Furthermore, decreased eNOS expression in the F98 group was associated by blunted eNOS-mediated vasomotor responses (Figure 4 and 5) in resistance vessels isolated from the same muscles. Accordingly, altered eNOS protein content in the skeletal muscle tissue samples were accepted as a strong evidence for the effect of altered shear stresses on endothelial eNOS expression.
The poloxamer-coating method used herein to enhance RBC aggregation in vivo is unique in that it does not involve the addition of foreign polymers to circulating blood: RBC are suspended in unaltered native plasma. In previous studies designed to assess the hemodynamic effects of RBC aggregation, high molecular weight polymers such as 500 kDa dextran have been utilized to increase RBC aggregation (6, 11, 19, 35, 48) . The use of these large polymers has been proven to be effective for modifying RBC aggregation, yet has potential disadvantages: 1) Plasma or suspending phase viscosity is increased (e.g., for 500 kDa dextran, 1.5 g/dL yields a 80% increase of suspending medium viscosity, see (43) The latter point is also somewhat relevant to the coated cells used herein, although it is notable that the degree of aggregation for Pluronic F98-coated cells decreased by less than 30% over the four-day period following exchange transfusion (Figures 1   and 2 ). The poloxamers used herein are not toxic at the concentrations that the experimental animals were exposed to but can be nephrotoxic at very high concentrations (57) . The use of poloxamer-coated red cells (4,5) thus appears to represent an improved approach for investigating the in vivo effects of RBC aggregation. 
